I-2-Chloromandalic Acid CAS 10421-85-9 Assay ≥99.0% Umfanekiso oPhakamileyo ococekileyo

I-2-Chloromandalic Acid CAS 10421-85-9 Assay ≥99.0% Ucoceko oluPhezulu

Inkcazelo emfutshane:

Igama leKhemikhali: I-2-Chloromandalic Acid

CAS: 10421-85-9

Imbonakalo: Umgubo weCrystalline oMhlophe okanye oMhlophe

Uvavanyo: ≥99.0%

Umgangatho ophezulu, iMveliso yoRhwebo

Inquiry: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Ubonelelo lwabavelisi ngoBusulungekileyo obuPhezulu kunye noMgangatho oZinzileyo
(S)-(+)-2-Chloromandalic Acid CAS: 52950-19-3
(R)-(-)-2-Chloromandalic Acid CAS: 52950-18-2
I-2-Chloromandalic Acid CAS: 10421-85-9
IiCompounds zeChiral, uMgangatho oPhezulu, iMveliso yoRhwebo

Iipropati zeMichiza:

Igama leMchiza	I-2-Chloromandelic Acid
Izithethantonye	I-DL-2-Chloro Mandelic Acid
Inombolo yeCAS	10421-85-9
Inombolo yeCAT	RF-PI247
Ubume beStokhwe	Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli	C8H7ClO3
Ubunzima beMolekyuli	186.59
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Umgubo weCrystalline oMhlophe okanye oMhlophe
I-Mandelic Acid	≤0.10%
2-Chlorobenzaldehyde	≤0.10%
Ukujikeleziswa okuthe ngqo	-0.1 ° ~ +0.1 °
Indawo yokunyibilika	86.0 ~ 92.0℃
Ukungacoceki Okukodwa	≤0.20%
Ukungcola ngokupheleleyo	≤1.0%
Ukufuma (KF)	≤0.50%
Ilahleko ekomisweni	≤0.50%
Isivavanyi	≥99.0%
Umgangatho woVavanyo	Umgangatho woShishino
Ukusetyenziswa	Phakathi kwezamayeza;I-Organic Synthesis

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.

Izinto eziluncedo:

FAQ:

Isicelo:

I-Shanghai Ruifu Chemical Co., Ltd. ngumvelisi ohamba phambili kunye nomthengisi we-2-Chloromandalic Acid (CAS: 10421-85-9) enomgangatho ophezulu, esetyenziswa ngokubanzi kwi-organic synthesis, i-synthesis ye-pharmaceutical intermediates kunye ne-Active Pharmaceutical Ingredient (API) synthesis. .